Postoperative fast-track recovery protocols combine various methods to support immediate care of patients who undergo major surgery. These protocols include control of postoperative pain and early beginning of oral diet and mobilization. The combination of these approaches may reduce the rate of postoperative complications and facilitate hospital discharge. The aim of this study was to evaluate progress and parameters of fast-track recovery after major liver and pancreatic resection. A descriptive bibliographical review from 2001 to 2012 via electronic databases such as MEDLINE, PubMed, and Google Scholar was undertaken. Articles that focused on a fast-track protocol were studied. Reports focusing on the implementation of a fast-track protocol in the postoperative recovery of patients after major hepatectomy or pancreatectomy were selected. Fast-track protocols may be applicable to patients recovering after major liver or pancreatic resection. Future research should be focused on particular parameters of the fast-track protocol separately.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/SGA.0000000000000049 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Rapid-recovery protocol for minimally invasive mitral valve repair.
JTCVS Open
December 2024
Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada.
Background: Minimally invasive mitral valve repair (MIMVR), often performed within specialized care pathways, has been shown to reduce hospital length of stay and improve patient recovery. The relative value of rapid-recovery protocols as a component of care pathways, including enhanced recovery programs (ERPs), has not been well described. This study compared clinical outcomes following implementation of a new, comprehensive rapid-recovery protocol within a previously established, mature ERP for patients undergoing MIMVR.
View Article and Find Full Text PDFAn Ultra-Fast Validated Green UPLC-MS/MS Approach for Assessing Revumenib in Human Liver Microsomes: In Vitro Absorption, Distribution, Metabolism, and Excretion and Metabolic Stability Evaluation.
Medicina (Kaunas)
November 2024
Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Revumenib (SNDX-5613) is a powerful and specific inhibitor of the menin-KMT2A binding interaction. It is a small molecule that is currently being researched to treat KMT2A-rearranged (KMT2Ar) acute leukemias. Revumenib (RVB) has received Orphan Drug Designation from the US FDA for treating patients with AML.
View Article and Find Full Text PDFA qualitative exploration of perioperative subjective experiences of colorectal cancer patients undergoing fast-track surgery.
Sci Rep
December 2024
Neurology Department, Shenzhen Bao'an District Songgang People's Hospital, 2 Shajiang Road, Songgang Jiedao, Bao'an District, Shenzhen, 518105, Guangdong Province, China.
Colorectal cancer significantly impacts patient quality of life and burdens healthcare systems globally. Fast-track surgery (FTS) aims to alleviate some of these impacts by expediting recovery and reduce the physiological stress associated with traditional surgical approaches. Despite the clinical efficiency of FTS, there exists a gap in the literature concerning patients' subjective experiences during the perioperative period.
View Article and Find Full Text PDFQuality of plastic surgery Enhanced Recovery After Surgery (ERAS) studies: A systematic review.
J Plast Reconstr Aesthet Surg
November 2024
McMaster University, Department of Surgery, Division of Plastic Surgery, Hamilton, ON, Canada; McMaster University, Department of Health Research Methods, Evidence and Impact (HEI), Hamilton, ON, Canada. Electronic address:
Background: In effort to improve post-operative outcomes, enhanced recovery after surgery (ERAS) protocols have gained popularity. The objective of this systematic review was to assess the reporting and methodological quality of plastic surgery ERAS studies.
Methods: All plastic surgery ERAS implementation studies, published between January 1, 2020, to November 20, 2023, were included.
[Minimally invasive trans-axillary approach and ultra-fast-track management: a new paradigm for mitral valve disease treatment].
G Ital Cardiol (Rome)
January 2025
Cardiochirurgia, Azienda Ospedaliero Universitaria delle Marche, Università Politecnica delle Marche, Ancona.
Background: The introduction of transcatheter procedures has focused on patient expectations for treatments with a less invasive approach and faster recovery. The aim of this study was to assess the short- and medium-term results in patients who underwent trans-axillary mitral valve repair with application of the ultra-fast-track protocol.
Methods: Data from 431 patients undergoing isolated trans-axillary mitral valve repair or associated with tricuspid valve treatment between January 2018 and December 2023 were prospectively collected.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!